Informative method to identify biomarkers for guiding therapy decisions

A randomised biomarker-stratified design, which uses the biomarker to guide analysis but not treatment assignment, provides a rigourous assessment of the utility of a potential biomarker for guiding therapy, according to a commentary published online January 14 in the Journal of the National Cancer Institute...

Read the whole article on

More from